Transfection Technologies Global Market Analysis, Trends,

Transfection Technologies Global Market Analysis

The Business Research Company recently released a comprehensive report on the Global Transfection Technologies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

According to The Business Research Company’s, The transfection technologies market size has grown strongly in recent years. It will grow from $1.11 billion in 2023 to $1.21 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, expanded applications of transfection technologies, growing demand for cell & gene therapy, increasing R&D investments, and rising cancer incidences.

The transfection technologies market size is expected to see strong growth in the next few years. It will grow to $1.70 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the rising rate of chronic and immunological diseases, the growing need for cell-based therapies, increasing demand for protein production, rising investments and funding in the development of drug delivery systems, and rising demand for monoclonal antibodies. Major trends in the forecast period include a rise in research and development in the field of cell-based therapies, adoption of the technologically advanced transfection method, increasing demand for advanced therapeutic delivery systems, increasing use of dual-reporter assays and co-transfection experiments, and increasing focus on personalized medicine.

Get The Complete Scope Of The Report @

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Market Drivers and Trends:

The rise in gene therapy is expected to propel the growth of the transfection technologies market going forward. Gene therapy is a technique that aims to treat or prevent diseases by modifying genes, which includes inserting, repairing, or replacing faulty genes. Gene therapy’s rise is driven by progress in genetic research, enhanced delivery methods, and its ability to treat previously incurable genetic conditions. Transfection technologies are crucial for gene therapy, facilitating the precise, safe, and effective delivery of genetic material into cells. They support both temporary and permanent genome modifications, essential for treating genetic diseases and cancers. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, by the end of the first quarter (Q1) of 2023, there were 247 gene therapies in Phase II. This number increased by 5%, reaching 260 by the end of the second quarter (Q2). Therefore, the rise in gene therapy is driving the growth of the transfection technologies market.

Major companies in the transfection technologies market are focused on developing advanced technology, such as mechanoporation transfection systems, to enable more complex and personalized applications in research and therapeutics. Mechanoporation transfection systems use mechanical forces to create temporary pores in cell membranes, allowing genetic material to enter cells. This method is efficient and minimally invasive, preserving better cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system includes a benchtop unit and the CellPore Transfection Kit 300, which comes with a specialized reagent kit and single-use delivery cartridges. Using controlled, rapid deformation in microfluidic channels, CellPore efficiently introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These features are critical for advancing research and the development of cutting-edge cell and gene therapies.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.

• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.

• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.

• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.

• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Transfection Technologies Market 2024 Key Insights:

• The transfection technologies market size is expected to see strong growth in the next few years. It will grow to $1.70 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%.

• Growth In Gene Therapy Fuels Expansion Of The Transfection Technologies Market

• Advancements In Mechanoporation Technology For Enhanced Cell Transfection

• North America was the largest region in the transfection technologies market in 2023

We Offer Customized Report, Click @

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn:

Twitter:

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC’s consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.